Accordingly, the co-expression of both genes, ALK and HDAC8, was correlated with poor survival of neuroblastoma patients in both cohorts, with long-term overall and event-free survival below 50% (Table 1; Fig. 3g, h). This evidence concerns the gene ALK and neuroblastoma.